Changes in the chemical barrier composition of tears in Alzheimer's disease reveal potential tear diagnostic biomarkers

PLoS ONE

Volumn 11, Issue 6, 2016, Pages

  Kalló, Gergo ^a   Emri, Miklós ^a   Varga, Zsófia ^a   Ujhelyi, Bernadett ^a   Tozsér, József ^a   Csutak, Adrienne ^a   Csosz, Éva ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; DERMCIDIN; LACRITIN; LIPOCALIN 1; LYSOZYME; LYSOZYME C; TEAR PROTEIN; UNCLASSIFIED DRUG; EYE PROTEIN; TEAR PROTEINS;

AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HUMAN; LACRIMAL FLUID; MALE; MEASUREMENT ACCURACY; PREDICTION; PREDICTIVE VALUE; PROTEIN ANALYSIS; PROTEOMICS; SELECTED REACTION MONITORING; SENSITIVITY AND SPECIFICITY; TEAR FLOW; VERY ELDERLY; CHEMISTRY; FLOW KINETICS; METABOLISM; MIDDLE AGED; RECEIVER OPERATING CHARACTERISTIC;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; BIOMARKERS; EYE PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTEOMICS; RHEOLOGY; ROC CURVE; TEARS;

EID: 84976863903     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0158000     Document Type: Article

References (48)

1. Qiu C, Kivipelto M, von Strauss E. Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention. Dialogues Clin Neurosci. 2009; 11: 111-28. PMID: 19585947
2. Bali J, Ben Halima S, Felmy B, Goodger Z, Zurbriggen S, Rajendran L. Cellular basis of Alzheimer's disease. Ann Indian Acad Neurol. 2010; 13: S89-93. doi: 10.4103/0972-2327.74251 PMID: 21369424
3. Crews L, Tsigelny I, Hashimoto M, Masliah E. Role of synucleins in Alzheimer's disease. Neurotox Res. 2009; 16: 306-317. doi: 10.1007/s12640-009-9073-6 PMID: 19551456
4. Love S. Contribution of cerebral amyloid angiopathy to Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2004; 75: 1-4. Available: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid= 1757461&tool=pmcentrez&rendertype=abstract PMID: 14707293
5. Koronyo-Hamaoui M, Koronyo Y, Ljubimov A V., Miller C a., Ko MK, Black KL, et al. Identification of amyloid plaques in retinas from Alzheimer's patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model. Neuroimage. Elsevier Inc.; 2011; 54: S204-S217. doi: 10.1016/j. neuroimage.2010.06.020
6. Goldstein LE, Muffat JA, Cherny RA, Moir RD, Ericsson MH, Huang X, et al. Cytosolic beta-amyloid deposition and supranuclear cataracts in lenses from people with Alzheimer's disease. Lancet (London, England). 2003; 361: 1258-65. doi: 10.1016/S0140-6736(03)12981-9
7. Armstrong RA. Alzheimer's Disease and the Eye. J Optom. Elsevier; 2009; 2: 103-111. doi: 10.3921/ joptom.2009.103
8. Prvulovic D, Hampel H. Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease. Clin Chem Lab Med. 2011; 49: 367-374. doi: 10.1515/CCLM.2011.087 PMID: 21342022
9. Wyss-coray T, Rogers J. Inflammation in Alzheimer Disease-A Brief Review of the Basic Science and Clinical Literature. Cold Spring Harb Perspect Biol. 2012; 1-24.
10. Korolainen M a, Goldsteins G, Nyman T a, Alafuzoff I, Koistinaho J, Pirttilä T. Oxidative modification of proteins in the frontal cortex of Alzheimer's disease brain. Neurobiol Aging. 2006; 27: 42-53. doi: 10. 1016/j.neurobiolaging.2004.11.010 PMID: 16298240
11. Takuma K, Yan SS, Stern DM, Yamada K. Mitochondrial dysfunction, endoplasmic reticulum stress, and apoptosis in Alzheimer's disease. J Pharmacol Sci. 2005; 97: 312-316. doi: 10.1254/jphs. CPJ04006X PMID: 15750290
12. Mueller SG, Weiner MW, Thal LJ, Petersen RC, Jack CR, Jagust W, et al. Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI). Alzheimers Dement. 2005; 1: 55-66. doi: 10.1016/j.jalz.2005.06.003 PMID: 17476317
13. Laske C, Sohrabi HR, Frost SM, López-de-Ipiña K, Garrard P, Buscema M, et al. Innovative diagnostic tools for early detection of Alzheimer's disease. Alzheimers Dement. 2015; 11: 561-78. doi: 10.1016/j. jalz.2014.06.004 PMID: 25443858
14. Korolainen M a., Nyman T a., Aittokallio T, Pirttilä T. An update on clinical proteomics in Alzheimer's research. J Neurochem. 2010; 112: 1386-1414. doi: 10.1111/j.1471-4159.2009.06558.x PMID: 20050976
15. Kim DH, Yeo SH, Park J-M, Choi JY, Lee T-H, Park SY, et al. Genetic markers for diagnosis and pathogenesis of Alzheimer's disease. Gene. Elsevier B.V.; 2014; 545: 185-193. doi: 10.1016/j.gene.2014. 05.031
16. Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet. 2009; 41: 1088-1093. doi: 10.1038/ng.440 PMID: 19734902
17. Podtelezhnikov AA, Tanis KQ, Nebozhyn M, Ray WJ, Stone DJ, Loboda AP. Molecular insights into the pathogenesis of Alzheimer's disease and its relationship to normal aging. PLoS One. 2011; 6: e29610.doi: 10.1371/journal.pone.0029610 PMID: 22216330
18. Korolainen M a, Nyman T a, Nyyssönen P, Hartikainen ES, Pirttilä T. Multiplexed proteomic analysis of oxidation and concentrations of cerebrospinal fluid proteins in Alzheimer disease. Clin Chem. 2007; 53: 657-65. doi: 10.1373/clinchem.2006.078014 PMID: 17289803
19. Picotti P, Aebersold R. Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions. Nat Methods. 2012; 9: 555-66. doi: 10.1038/nmeth.2015 PMID: 22669653
20. Lange V, Picotti P, Domon B, Aebersold R. Selected reaction monitoring for quantitative proteomics: a tutorial. Mol Syst Biol. 2008; 4: 222. doi: 10.1038/msb.2008.61 PMID: 18854821
21. Kalló G, Chatterjee A, Tóth M, Rajnavölgyi É, Csutak A, Tõzsér J, et al. Relative quantification of human β-defensins by a proteomics approach based on selected reaction monitoring. Rapid Commun Mass Spectrom. 2015; 29: 1623-1631. doi: 10.1002/rcm.7259 PMID: 26467114
22. Zhou L, Zhao SZ, Koh SK, Chen L, Vaz C, Tanavde V, et al. In-depth analysis of the human tear proteome. J Proteomics. Elsevier B.V.; 2012; 75: 3877-3885. doi: 10.1016/j.jprot.2012.04.053
23. Zhou L, Beuerman RW, Chan CM, Zhao SZ, Li XR, Yang H, et al. Identification of tear fluid biomarkers in dry eye syndrome using iTRAQ quantitative proteomics. J Proteome Res. 2009; 8: 4889-905. doi: 10.1021/pr900686s PMID: 19705875
24. Herber S, Grus FH, Sabuncuo P, Augustin AJ. Two-dimensional analysis of tear protein patterns of diabetic patients. Electrophoresis. 2001; 22: 1838-44. PMID: 11425240
25. Csosz É, Boross P, Csutak A, Berta A, Tóth F, Póliska S, et al. Quantitative analysis of proteins in the tear fluid of patients with diabetic retinopathy. J Proteomics. 2012; 75: 2196-2204. doi: 10.1016/j.jprot. 2012.01.019 PMID: 22300579
26. An HJ, Ninonuevo M, Aguilan J, Liu H, Lebrilla CB, Alvarenga LS, et al. Glycomics analyses of tear fluid for the diagnostic detection of ocular rosacea. J Proteome Res. 4: 1981-7. doi: 10.1021/pr0501620PMID: 16335942
27. Haeckel R, Hänecke P. The application of saliva, sweat and tear fluid for diagnostic purposes. Ann Biol Clin (Paris). 1993; 51: 903-10. Available: http://www.ncbi.nlm.nih.gov/pubmed/8210068
28. Sperandio B, Fischer N, Sansonetti PJ. Mucosal physical and chemical innate barriers: Lessons from microbial evasion strategies. Semin Immunol. Elsevier Ltd; 2015; 27: 111-118. doi: 10.1016/j.smim. 2015.03.011
29. Çomoǧlu SS, Güven H, Acar M, Öztürk G, Koçer B. Tear levels of tumor necrosis factor-alpha in patients with Parkinson's disease. Neurosci Lett. 2013; 553: 63-67. doi: 10.1016/j.neulet.2013.08.019PMID: 23973333
30. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984; 34: 939-44. Available: http://www.ncbi.nlm.nih.gov/pubmed/6610841 PMID: 6610841
31. Diagnostic and Statistical Manual of Mental Disorders Source Information [Internet]. U.S. National Library of Medicine; Available: https://www.nlm.nih.gov/research/umls/sourcereleasedocs/current/DSM4/
32. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12: 189-198. 0022-3956(75)90026-6 [pii] PMID: 1202204
33. Berta A. Collection of tear samples with or without stimulation. Am J Ophthalmol. 1983; 96: 115-6.Available: http://www.ncbi.nlm.nih.gov/pubmed/6869470 PMID: 6869470
34. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72: 248-54. Available: http://www.ncbi. nlm.nih.gov/pubmed/942051 PMID: 942051
35. Choi M, Chang C-Y, Clough T, Broudy D, Killeen T, MacLean B, et al. MSstats: an R package for statistical analysis of quantitative mass spectrometry-based proteomic experiments. Bioinformatics. 2014; 30: 2524-6. doi: 10.1093/bioinformatics/btu305 PMID: 24794931
36. Bates D, Mächler M, Bolker B, Walker S. Fitting Linear Mixed-Effects Models Using lme4. J Stat Softw. 2015; 67. doi: 10.18637/jss.v067.i01
37. Hochberg Y. Controlling the False Discovery Rate: a Practical and Powerful Approach to Multiple Testing When researchers tend to select pursuing multiple the (statistically) and support of conclusions. An unguarded use in a greatly results of single-inference inc. 2015; 57: 289-300.
38. Shultz EK. Multivariate receiver-operating characteristic curve analysis: prostate cancer screening as an example. Clin Chem. 1995; 41: 1248-55. Available: http://www.ncbi.nlm.nih.gov/pubmed/7628115PMID: 7628115
39. Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez J-C, et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011; 12: 77. doi: 10.1186/ 1471-2105-12-77 PMID: 21414208
40. Fullard RJ, Snyder C. Protein levels in nonstimulated and stimulated tears of normal human subjects. Invest Ophthalmol Vis Sci. 1990; 31: 1119-1126. PMID: 2354914
41. Sugi K, Saitoh O, Hirata I, Katsu K. Fecal lactoferrin as a marker for disease activity in inflammatory bowel disease: comparison with other neutrophil-derived proteins. Am J Gastroenterol. 1996; 91: 927-34. Available: http://www.ncbi.nlm.nih.gov/pubmed/8633583 PMID: 8633583
42. Rieg S, Steffen H, Seeber S, Humeny A, Kalbacher H, Dietz K, et al. Deficiency of dermcidin-derived antimicrobial peptides in sweat of patients with atopic dermatitis correlates with an impaired innate defense of human skin in vivo. J Immunol. 2005; 174: 8003-8010. doi: 10.1016/S0093-3619(08)70018-2 PMID: 15944307
43. Mumcu G, Cimilli H, Karacayli U, Inanc N, Ture-Ozdemir F, Eksioglu-Demiralp E, et al. Salivary levels of antimicrobial peptides Hnp 1-3, Ll-37 and S100 in Behcet's disease. Arch Oral Biol. Elsevier Ltd; 2012; 57: 642-6.
44. Csosz É, Emri G, Kalló G, Tsaprailis G, Tozsér J. Highly abundant defense proteins in human sweat asrevealed by targeted proteomics and label-free quantification mass spectrometry. J Eur Acad Dermatology Venereol. 2015; 29: 2024-2031. doi: 10.1111/jdv.13221
45. Ullrich A, Sures I, D'Egidio M, Jallal B, Powell TJ, Herbst R, et al. The secreted tumor-associated antigen90K is a potent immune stimulator. J Biol Chem. 1994; 269: 18401-18407. PMID: 8034587
46. Schittek B. The multiple facets of dermcidin in cell survival and host defense. J Innate Immun. 2012; 4: 349-360.
47. Wiesner J, Vilcinskas A. Antimicrobial peptides: the ancient arm of the human immune system. Virulence. 2010; 1: 440-464. doi: 10.4161/viru.1.5.12983 PMID: 21178486
48. Örnek N, Daǧ E, Örnek K. Corneal Sensitivity and Tear Function in Neurodegenerative Diseases. Curr Eye Res. 2015; 40: 423-428. doi: 10.3109/02713683.2014.930154 PMID: 24955505